Clinical Research Directory
Browse clinical research sites, groups, and studies.
Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study
Sponsor: Sanoculis Ltd
Summary
A long-term (24 and 30 months) follow-up extension, prospective, non-interventional, open label study for data collection from subjects who underwent prior MIMS® inferonasal surgery, in continuation of the previous clinical investigation with the MIMS® Device (MMS-EEU-5).
Official title: Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure: Long-Term Follow-Up Extension Study
Key Details
Gender
All
Age Range
40 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
53
Start Date
2022-11-04
Completion Date
2025-06-30
Last Updated
2024-09-26
Healthy Volunteers
Not specified
Conditions
Interventions
Inferonasal Minimally Invasive Micro Sclerostomy
The Inferonasal MIMS® procedure uses the proprietary MIMS® device, which creates a sclerostomy in the inferonasal quadrant of the eye.
Locations (1)
S. Malayan Eye Center
Yerevan, Armenia